The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.
-
(2008/06/13)
Pyrazolopyrimidines as therapeutic agents
The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.
-
(2008/06/13)
More Articles about upstream products of 330790-87-9
Get Best Price for330790-87-9N1-[4-(4-amino-1-{2-[(2R)-2-(hydroxymethyl)tetrahydro-1H-1-pyrrolyl]-2-oxoethyl}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,3-dichloro-1-benzenesulfonamide